£10.0M
The round was led by BGF with participation from Parkwalk, Cambridge Enterprise, and Cambridge Innovation Capital.
P
PredictImmune
PredictImmune develops prognostic tools for guiding treatment in immune-mediated diseases.
£10.0MTotal raised
PredictImmune develops pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases. The company offers products such as PredictSURE IBD to support personalised medicine.
Categories
Founders
KS
Ken Smith
Head of the Department of Medicine